Working… Menu

An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00214838
Recruitment Status : Unknown
Verified December 2006 by Callisto Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : September 22, 2005
Last Update Posted : December 5, 2006
Information provided by:
Callisto Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Unknown
Primary Completion Date : No date given
Study Completion Date : March 2007